Quick Answer
ENANTA PHARMACEUTICALS INC reported Stockholders Equity of $64.72 million for fiscal year 2025.
ENANTA PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $64.72M | -49.8% |
| 2024 | $128.81M | -40.6% |
| 2023 | $216.74M | -32.6% |
| 2022 | $321.33M | -19.6% |
| 2021 | $399.43M | -12.3% |
| 2020 | $455.58M | -1.5% |
| 2019 | $462.49M | +17.5% |
| 2018 | $393.68M | +30.5% |
| 2017 | $301.68M | +11.8% |
| 2016 | $269.94M | +14.3% |
| 2015 | $236.16M | +58.9% |
| 2014 | $148.65M | +34.6% |
| 2013 | $110.47M | +195.8% |
| 2012 | -$115.35M | +12.6% |
| 2011 | -$131.96M | +12.1% |
| 2010 | -$150.07M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $126.59M | +13.2% | +95.6% |
| September 30, 2025 | $64.72M | -49.8% | -18.4% |
| June 30, 2025 | $79.28M | -46.8% | -15.2% |
| March 31, 2025 | $93.54M | -43.7% | -16.3% |
| December 31, 2024 | $111.82M | -41.7% | -13.2% |
| September 30, 2024 | $128.81M | -40.6% | -13.5% |
| June 30, 2024 | $148.91M | -37.4% | -10.4% |
| March 31, 2024 | $166.11M | -38.3% | -13.4% |
- ENANTA PHARMACEUTICALS INC showed a decrease of -49.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, ENANTA PHARMACEUTICALS INC’s stockholders equity has grown by 143.1% (from -$150.07 million to $64.72 million).
- The most recent figure is from ENANTA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: